Molecular signature of MT1-MMP: transactivation of the downstream universal gene network in cancer.

Invasion-promoting MT1-MMP is directly linked to tumorigenesis and metastasis. Our studies led us to identify those genes, the expression of which is universally linked to MT1-MMP in multiple tumor types. Genome-wide expression profiling of MT1-MMP-overexpressing versus MT1-MMP-silenced cancer cells and a further data mining analysis of the preexisting expression database of 190 human tumors of 14 cancer types led us to identify 11 genes, the expression of which correlated firmly and universally with that of MT1-MMP (P < 0.00001). These genes included regulators of energy metabolism (NNT), trafficking and membrane fusion (SLCO2A1 and ANXA7), signaling and transcription (NR3C1, JAG1, PI3K delta, and CK2 alpha), chromatin rearrangement (SMARCA1), cell division (STK38/NDR1), apoptosis (DAPK1), and mRNA splicing (SNRPB2). Our subsequent extensive analysis of cultured cells, tumor xenografts, and cancer patient biopsies supported our data mining. Our results suggest that transcriptional reprogramming of the specific downstream genes, which themselves are associated with tumorigenesis, represents a distinctive "molecular signature" of the proteolytically active MT1-MMP. We suggest that the transactivation activity of MT1-MMP contributes to the promigratory cell phenotype, which is induced by this tumorigenic proteinase. The activated downstream gene network then begins functioning in unison with MT1-MMP to rework the signaling, transport, cell division, energy metabolism, and other critical cell functions and to commit the cell to migration, invasion, and, consequently, tumorigenesis.

[1]  O. Kassel,et al.  Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP‐1 , 2001, The EMBO journal.

[2]  Chen Dong,et al.  MAP kinases in the immune response. , 2002, Annual review of immunology.

[3]  A. Strongin,et al.  Tissue Inhibitor of Metalloproteinases-2 Binding to Membrane-type 1 Matrix Metalloproteinase Induces MAPK Activation and Cell Growth by a Non-proteolytic Mechanism* , 2008, Journal of Biological Chemistry.

[4]  Lewis C Cantley,et al.  The phosphoinositide 3-kinase pathway. , 2002, Science.

[5]  T. Poggio,et al.  Multiclass cancer diagnosis using tumor gene expression signatures , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[6]  John Calvin Reed,et al.  Claudin‐1 immunohistochemistry for distinguishing malignant from benign epithelial lesions of prostate , 2007, The Prostate.

[7]  A. Strongin,et al.  Aberrant, persistent inclusion into lipid rafts limits the tumorigenic function of membrane type-1 matrix metalloproteinase in malignant cells. , 2004, Experimental cell research.

[8]  Z. Werb,et al.  New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.

[9]  T. Isobe,et al.  Membrane Type 1 Matrix Metalloproteinase (MT1-MMP/MMP-14) Cleaves and Releases a 22-kDa Extracellular Matrix Metalloproteinase Inducer (EMMPRIN) Fragment from Tumor Cells* , 2006, Journal of Biological Chemistry.

[10]  R. Fridman,et al.  Processing, shedding, and endocytosis of membrane type 1‐matrix metalloproteinase (MT1‐MMP) , 2004, Journal of cellular physiology.

[11]  O. Kallioniemi,et al.  Prognostic Impact of ANX7-GTPase in Metastatic and HER2-Negative Breast Cancer Patients , 2004, Clinical Cancer Research.

[12]  A. Strongin,et al.  Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis. , 2002, Cancer research.

[13]  K. Yoshioka,et al.  Membrane Type 1 Matrix Metalloproteinase Regulates Collagen-Dependent Mitogen-Activated Protein/Extracellular Signal-Related Kinase Activation and Cell Migration , 2004, Cancer Research.

[14]  O. Issinger,et al.  Protein kinase CK2 and its role in cellular proliferation, development and pathology , 1999, Electrophoresis.

[15]  F. Ashcroft,et al.  Nicotinamide nucleotide transhydrogenase: a key role in insulin secretion. , 2006, Cell metabolism.

[16]  M. Hendrix,et al.  Phosphoinositide 3-kinase regulates membrane Type 1-matrix metalloproteinase (MMP) and MMP-2 activity during melanoma cell vasculogenic mimicry. , 2003, Cancer research.

[17]  L. Pinna,et al.  Protein kinase CK2. , 2013, The international journal of biochemistry & cell biology.

[18]  J. Hogg,et al.  Activation of a tumor-associated protein kinase (p40TAK) and casein kinase 2 in human squamous cell carcinomas and adenocarcinomas of the lung. , 1994, Cancer research.

[19]  S. Varambally,et al.  JAGGED1 Expression Is Associated with Prostate Cancer Metastasis and Recurrence , 2004, Cancer Research.

[20]  S. Weiss,et al.  A cancer cell metalloprotease triad regulates the basement membrane transmigration program. , 2006, Genes & development.

[21]  Khalil Ahmed.  Significance of the casein kinase system in cell growth and proliferation with emphasis on studies of the androgenic regulation of the prostate. , 1994, Cellular & molecular biology research.

[22]  Y. Itoh,et al.  MT1‐MMP: A key regulator of cell migration in tissue , 2006, IUBMB life.

[23]  Stephen J. Weiss,et al.  Regulation of membrane-type matrix metalloproteinase 1 activity by dynamin-mediated endocytosis , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Qiang Zhou,et al.  Stimulatory effect of splicing factors on transcriptional elongation , 2001, Nature.

[25]  S. Bourgeois,et al.  Regulation of fibronectin biosynthesis by glucocorticoids in human fibrosarcoma cells and normal fibroblasts , 1983, Cell.

[26]  H. Nagasawa,et al.  Hypoxia accelerates cancer invasion of hepatoma cells by upregulating MMP expression in an HIF-1alpha-independent manner. , 2006, International journal of oncology.

[27]  O. Issinger,et al.  Casein kinase II is elevated in solid human tumours and rapidly proliferating non-neoplastic tissue. , 1990, European journal of biochemistry.

[28]  A. Strongin,et al.  The Hemopexin-like C-terminal Domain of Membrane Type 1 Matrix Metalloproteinase Regulates Proteolysis of a Multifunctional Protein, gC1qR* , 2002, The Journal of Biological Chemistry.

[29]  L. Ellerby,et al.  Release of caspase-9 from mitochondria during neuronal apoptosis and cerebral ischemia. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[30]  A. Strongin,et al.  Membrane type-1 matrix metalloproteinase confers aneuploidy and tumorigenicity on mammary epithelial cells. , 2006, Cancer research.

[31]  D. Hanahan,et al.  A transition in transcriptional activation by the glucocorticoid and retinoic acid receptors at the tumor stage of dermal fibrosarcoma development. , 1995, The EMBO journal.

[32]  A. Strongin,et al.  Mutation Analysis of Membrane Type-1 Matrix Metalloproteinase (MT1-MMP) , 2001, The Journal of Biological Chemistry.

[33]  Hiroshi Sato,et al.  Membrane-type 1 matrix metalloproteinase modulates focal adhesion stability and cell migration. , 2006, Experimental cell research.

[34]  A. Ruifrok,et al.  Quantification of histochemical staining by color deconvolution. , 2001, Analytical and quantitative cytology and histology.

[35]  M. Bernardo,et al.  Binding of Active (57 kDa) Membrane Type 1-Matrix Metalloproteinase (MT1-MMP) to Tissue Inhibitor of Metalloproteinase (TIMP)-2 Regulates MT1-MMP Processing and Pro-MMP-2 Activation* , 2000, The Journal of Biological Chemistry.

[36]  Stefanie S Jeffrey,et al.  A molecular 'signature' of primary breast cancer cultures; patterns resembling tumor tissue , 2004, BMC Genomics.

[37]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[38]  Y. Sadovsky,et al.  N-Myc Down-regulated Gene 1 Modulates the Response of Term Human Trophoblasts to Hypoxic Injury* , 2006, Journal of Biological Chemistry.

[39]  A. Strongin,et al.  Interference with the complement system by tumor cell membrane type-1 matrix metalloproteinase plays a significant role in promoting metastasis in mice. , 2006, Cancer research.

[40]  J. Hériché,et al.  Regulation of protein phosphatase 2A by direct interaction with casein kinase 2alpha. , 1997, Science.

[41]  Yi Xing,et al.  ASAP: the Alternative Splicing Annotation Project , 2003, Nucleic Acids Res..

[42]  A. Strongin,et al.  O-Glycosylation Regulates Autolysis of Cellular Membrane Type-1 Matrix Metalloproteinase (MT1-MMP)* , 2006, Journal of Biological Chemistry.

[43]  K. Ahmed,et al.  Elevated protein kinase CK2 activity in chromatin of head and neck tumors: association with malignant transformation. , 1996, Cancer letters.

[44]  I. Pettersson,et al.  U2‐SnRNP B″ protein gene is an early growth‐inducible gene , 1995, Journal of cellular biochemistry.

[45]  E. Thompson,et al.  The promoter and first, untranslated exon of the human glucocorticoid receptor gene are GC rich but lack consensus glucocorticoid receptor element sites , 1990, Molecular and cellular biology.

[46]  L. Pinna,et al.  Protein kinase CK2 ("casein kinase-2") and its implication in cell division and proliferation. , 1997, Progress in cell cycle research.

[47]  J. Gutkind,et al.  MT1-MMP Controls Tumor-induced Angiogenesis through the Release of Semaphorin 4D* , 2007, Journal of Biological Chemistry.

[48]  Munirah Ahmad,et al.  Cleavage of Lumican by Membrane-Type Matrix Metalloproteinase-1 Abrogates This Proteoglycan-Mediated Suppression of Tumor Cell Colony Formation in Soft Agar , 2004, Cancer Research.

[49]  Y. Okada,et al.  Constitutive and Induced CD44 Shedding by ADAM-Like Proteases and Membrane-Type 1 Matrix Metalloproteinase , 2004, Cancer Research.

[50]  A. Strongin,et al.  Membrane Type-1 Matrix Metalloproteinase (MT1-MMP) Exhibits an Important Intracellular Cleavage Function and Causes Chromosome Instability* , 2005, Journal of Biological Chemistry.

[51]  J. Keski‐Oja,et al.  Co-recycling of MT1-MMP and MT3-MMP through the Trans-Golgi Network , 2004, Journal of Biological Chemistry.